SynthesisDigestive diseases and sciences2026
Risk Factors of Post-ESD Electrocoagulation Syndrome for Colorectal Neoplasms: A Systematic Review and Comprehensive Meta-Analysis.
Synthesis in Digestive diseases and sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Endoscopic Closure After Colorectal ESD: A Literature Review and Meta-Analysis on Its Efficacy in Preventing Adverse Events.Diagnostics (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND AND
aimsEndoscopic submucosal dissection (ESD) has gained increasing popularity in the management of complicated colorectal polyps. Post-ESD electrocoagulation syndrome (PECS) has been recognized as one of the significant complications. Several studies have evaluated different risk factors associated with post-endoscopic submucosal dissection electrocoagulation syndrome for colorectal neoplasms. In this meta-analysis, we aimed to identify the risk factors of PECS after colorectal ESD.
methodsA comprehensive literature search of PubMed, Embase, Web of Science Core Collection, and the Cochrane Database for Systematic Reviews was conducted from inception to February 05, 2025. All studies that used a multivariate model to assess risk factors for post-ESD electrocoagulation syndrome were included. Pooled odds ratios (OR) with 95% confidence intervals (CI) for risk factors reported in ≥ 2 studies were obtained within a random-effects model.
resultsNineteen studies (3 prospective, 2 RCTs, 14 retrospective studies) with 8151 patients who underwent endoscopic submucosal dissection for colorectal lesions were included. Pooled Incidence of PECS was 8.9%. Ten different risk factors were analyzed. Meta-analysis demonstrated that female gender OR 3.03 (2.16, 4.24), tumor size ≥ 20 mm OR 2.57 (1.65, 3.99), procedure time ≥ 60 min OR 2.25 (1.33, 3.79), tumor location in right sided colon OR 3.33 (1.85, 5.99), submucosal fibrosis OR 3.34 (1.65, 6.75), injury to muscle layer high OR 5.43 (3.04, 9.67) and high joule heat accumulation OR 10.01 (2.83, 35.40) were significant predictors of Post-ESD electrocoagulation syndrome. Older age ≥ 60 years, lesions in the left-sided colon (rectosigmoid), traction-assisted ESD, Tumor morphology LST-G type, non-lifting, and deep submucosal invasions were not significant risk factors in post-ESD electrocoagulation syndrome.
conclusionThis meta-analysis demonstrates that female sex, lesion size ≥ 20 mm, procedure time ≥ 60 min, right-sided location, submucosal fibrosis, muscle layer injury, and high Joule heat accumulation were associated with increased odds of PECS. Understanding these risk factors can help clinicians identify patients at higher risk of PECS and implement preventive measures to improve outcomes after colorectal ESD.
Indexed as
Identifiers
41483439What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.